Adjuvant therapy for resected pancreatic cancer

This publication has 43 references indexed in Scilit:

• Physician attitudes and treatment patterns for pancreatic cancer
  World Journal of Surgical Oncology, 2011
• Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010
  World Journal of Gastroenterology, 2011
• Epidemiology of Pancreatic Cancer: An Update
  Digestive Diseases, 2010
• Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study
  Journal of Clinical Oncology, 2010
• Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
  The Lancet, 2010
• A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
  British Journal of Cancer, 2009
• Is there under-treatment of pancreatic cancer? Evidence from a population-based study in Ireland
  European Journal of Cancer, 2009
• Classification of Surgical Complications
  Annals of Surgery, 2004
• Measuring inconsistency in meta-analyses
  BMJ, 2003
• Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater—results of a controlled, prospective, randomised multicentre study
  European Journal of Cancer, 1993